Free Trial

Summit Therapeutics (SMMT) Insider Trading & Ownership

Summit Therapeutics logo
$18.72 +0.64 (+3.56%)
As of 03:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
83.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$22.97M
Number Of
Insiders Selling
(Last 12 Months)
0
Get SMMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Summit Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SMMT Insider Buying and Selling by Quarter

Summit Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/21/2025Buy26,680$18.74$499,983.20  
10/21/2025Buy26,680$18.74$499,983.20  
10/21/2025
Yu Xia
Yu Xia
Director
Buy533,617$18.74$9,999,982.58  
9/11/2025Buy5,000$18.07$90,350.00  
9/11/2025Buy5,000$18.07$90,350.00  
9/10/2025Buy333,394$17.68$5,894,405.92  
9/10/2025Buy333,394$17.68$5,894,405.92  
(Data available from 1/1/2013 forward)

SMMT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Summit Therapeutics includes Ankur Dhingra, Mahkam Zanganeh, Manmeet Singh Soni, Robert W Duggan, and Yu Xia. Learn more on insiders at SMMT.

83.50% of Summit Therapeutics stock is owned by insiders. Learn more on SMMT's insider holdings.

The following insiders have purchased SMMT shares in the last 24 months: Mahkam Zanganeh ($6,484,739.12), Robert W Duggan ($6,484,739.12), and Yu Xia ($9,999,982.58).

Insiders have purchased a total of 1,263,765 SMMT shares in the last 24 months for a total of $22,969,460.82 bought.



This page (NASDAQ:SMMT) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners